Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-07-30
DOI
10.1016/j.annonc.2022.07.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Surgical Margins on Overall Survival after Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series
- (2022) Marianna Maspero et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients (pts) with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma (OGA): The GERCOR NEONIPIGA phase II study.
- (2022) Thierry Andre et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination
- (2022) Hiroshi Kobayashi et al. JOURNAL OF SURGICAL ONCOLOGY
- Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy
- (2022) Joe Yeong et al. Gastric Cancer
- Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score {greater than or equal to}10
- (2021) Zev A. Wainberg et al. CLINICAL CANCER RESEARCH
- Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial
- (2021) Zhihao Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials
- (2021) F. Pietrantonio et al. ESMO Open
- HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study
- (2021) Ivonne Haffner et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy
- (2021) Soomin Ahn et al. MODERN PATHOLOGY
- Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
- (2021) Joseph Chao et al. JAMA Oncology
- Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer
- (2021) Peter S. Hall et al. JAMA Oncology
- 1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
- (2021) S-E. Al-Batran et al. ANNALS OF ONCOLOGY
- 1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)
- (2021) B. Rau et al. ANNALS OF ONCOLOGY
- Endoscopic screening for gastric cancer in Japan: Current status and future perspectives
- (2021) Katsuhiro Mabe et al. Digestive Endoscopy
- Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
- (2021) Jong-Mu Sun et al. LANCET
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD , RAINBOW , and RAINFALL Phase III Studies
- (2021) Wasat Mansoor et al. ONCOLOGIST
- Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology
- (2021) Massimiliano Valletti et al. World Journal of Surgical Oncology
- Inherited Predisposition to Gastric Cancer
- (2021) Sheila D. Rustgi et al. Gastrointestinal Endoscopy Clinics of North America
- Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes
- (2021) José Garcia-Pelaez et al. European Journal of Medical Genetics
- 18F-Fludeoxyglucose–Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer
- (2021) Emma C. Gertsen et al. JAMA Surgery
- Japanese gastric cancer treatment guidelines 2018 (5th edition)
- (2020) Gastric Cancer
- Chemotherapy for resectable microsatellite instability-high gastric cancer?
- (2020) Elizabeth C Smyth LANCET ONCOLOGY
- Chemotherapy for resectable microsatellite instability-high gastric cancer?
- (2020) Florian Lordick LANCET ONCOLOGY
- Family History of Gastric Cancer and Helicobacter pylori Treatment
- (2020) Il Ju Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
- (2020) Kohei Shitara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global burden of oesophageal and gastric cancer by histology and subsite in 2018
- (2020) Melina Arnold et al. GUT
- Hereditary diffuse gastric cancer: updated clinical practice guidelines
- (2020) Vanessa R Blair et al. LANCET ONCOLOGY
- Documento de posicionamiento de la AEG, la SEED y la SEAP sobre cribado de cáncer gástrico en poblaciones con baja incidencia
- (2020) Joaquín Cubiella et al. Gastroenterologia y Hepatologia
- Gastric cancer
- (2020) Elizabeth C Smyth et al. LANCET
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
- (2020) Kohei Shitara et al. JAMA Oncology
- A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
- (2020) Se Hoon Park et al. ANNALS OF ONCOLOGY
- Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition)
- (2020) Hiroyuki Ono et al. Digestive Endoscopy
- Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial
- (2020) W.O. de Steur et al. ANNALS OF ONCOLOGY
- Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
- (2019) Pierre-Emmanuel Bonnot et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma
- (2019) Matthew Banks et al. GUT
- Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial
- (2019) Yasuhide Yamada et al. Lancet Gastroenterology & Hepatology
- Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
- (2019) Filippo Pietrantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
- (2019) Arash Etemadi et al. Lancet Gastroenterology & Hepatology
- Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer
- (2018) Karina Kulangara et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer
- (2018) William Allum et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
- (2018) Annemieke Cats et al. LANCET ONCOLOGY
- A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
- (2018) J Mateo et al. ANNALS OF ONCOLOGY
- Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants
- (2018) Kristy Lee et al. HUMAN MUTATION
- Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET ONCOLOGY
- Endoscopic submucosal dissection for early gastric cancer: are expanded resection criteria safe for Western patients?
- (2017) Andreas Probst et al. ENDOSCOPY
- Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG
- (2017) Kozo Kataoka et al. Gastric Cancer
- Endoscopic ultrasonography compared with multidetector computed tomography for the preoperative staging of gastric cancer: a meta-analysis
- (2017) Run-Cong Nie et al. World Journal of Surgical Oncology
- Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer
- (2017) Salah-Eddin Al-Batran et al. JAMA Oncology
- Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis
- (2016) R.F. Ramos et al. EJSO
- The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015
- (2016) Giovanni De Manzoni et al. Gastric Cancer
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
- (2016) Kazumasa Fujitani et al. LANCET ONCOLOGY
- Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
- (2015) Pedro Pimentel-Nunes et al. ENDOSCOPY
- Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer
- (2015) Naoyuki Tominaga et al. Gastric Cancer
- Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference
- (2015) Gian Luca Baiocchi et al. Gastric Cancer
- Comparison of laparoscopic versus open gastrectomy for advanced gastric cancer: an updated meta-analysis
- (2015) Yingjun Quan et al. Gastric Cancer
- Global patterns of cardia and non-cardia gastric cancer incidence in 2012
- (2015) A Colquhoun et al. GUT
- Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium
- (2015) Manish A. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
- (2015) Se Hoon Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea
- (2014) K S Choi et al. BRITISH JOURNAL OF CANCER
- Consensus guidelines for enhanced recovery after gastrectomy
- (2014) K. Mortensen et al. BRITISH JOURNAL OF SURGERY
- Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study
- (2014) Rosine Guimbaud et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Vitamin B12 Deficiency After Gastrectomy for Gastric Cancer
- (2013) Yanfeng Hu et al. ANNALS OF SURGERY
- Gastric Cancer
- (2013) Pelayo Correa GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial
- (2013) Shuichi Hironaka et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
- (2011) Jeeyun Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
- (2010) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric Cancer
- (2010) Johan L. Dikken et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
- (2008) M. Dank et al. ANNALS OF ONCOLOGY
- Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) S.-E. Al-Batran et al. ANNALS OF ONCOLOGY
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-term changes in bone and mineral metabolism following gastrectomy in gastric cancer patients
- (2007) Ki Hyun Baek et al. BONE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now